Laser-Irradiated Chlorpromazine as a Potent Anti-Biofilm Agent for Coating of Biomedical Devices
Source abstract
Abstract
Nowadays, antibiotic resistance has become increasingly common, triggering a global health crisis, immediately needing alternative, including repurposed drugs with potent bactericidal effects. We demonstrated that chlorpromazine aqueous solutions exposed to laser radiation exhibited visible activity against various microorganisms. The aim of this study was to investigate the quantitative antimicrobial activity of chlorpromazine in non-irradiated and 4-h laser irradiated form. Also, we examined the effect of both solutions impregnated on a cotton patch, cannula, and urinary catheter against Gram-positive Staphylococcus aureus and Gram-negative Pseudomonas aeruginosa and Escherichia coli. In all experimental versions, the chlorpromazine antimicrobial activity was enhanced by laser exposure. Besides the experimental results, the in silico analyses using molecular docking proved that the improved antimicrobial activity of the irradiated compound was a result of the combined action of the photoproducts on the biological target (s). Our results show that laser radiation could alter the molecular structure of various drugs and their effects, proving to be a promising strategy to halt antibiotic resistance, by repurposing current medicines for new antimicrobial strategies, thereby decreasing the costs and time for the development of more efficient drugs.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Phenothiazines and Benzothiazines Synthesis and Activities · Essential Oils and Antimicrobial Activity · Bacterial biofilms and quorum sensing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Institute for Laser, Plasma and Radiation Physics, 077125 Magurele, Romania
Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania
Research Institute of the University of Bucharest (ICUB), University of Bucharest, 050095 Bucharest, Romania
Faculty of Physics, University of Bucharest, 077125 Magurele, Romania
Academy of Romanian Scientists, 050045 Bucharest, Romania
Funding
UEFISCD · Nucleu Programme
References (56)
Show source-provided references
1. (2020, June 07). Annual Report of the Chief Medical Officer Volume Two, 2011. Infections and the Rise of Antimicrobial Resistance, Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/138331/CMO_Annual_Report_Volume_2_2011.pdf.
2. Schwarz, S., Cavaco, L.M., and Shen, J. (2018). Antimicrobial Resistance in Bacteria from Livestock and Companion Animals, American Society of Microbiology.10.1128/9781555819804 ↗
3. Microbiology of Root Canal Infections10.1308/205016816819304231 ↗
4. Characterization of microbial community composition, antimicrobial resistance and biofilm on intensive care surfaces10.1016/j.jiph.2017.10.005 ↗
5. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria10.1093/femsre/fux010 ↗
6. Physiological heterogeneity in biofilms10.1038/nrmicro1838 ↗
7. Nosocomial Infections—A Present and Future Challenge
8. World Health Organization (2011). Report on the Burden of Endemic Health Care-Associated Infection Worldwide, World Health Organization.
9. Nosocomial infections: Epidemiology, prevention, control and surveillance10.1016/j.apjtb.2017.01.019 ↗
10. (2014). Antimicrobial Resistance: Global Report on Surveillance, World Health Organization.
11. Healthcare-Associated Infection and Hospital Readmission10.1086/665725 ↗
12. The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida10.7326/0003-4819-136-11-200206040-00013 ↗
13. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action10.1080/21505594.2017.1313372 ↗
14. Evaluation of the Adherence of Candida Species to Urinary Catheters10.1023/B:MYCO.0000003559.59676.f7 ↗
15. Inactivation of antibiotics and the dissemination of resistance genes10.1126/science.8153624 ↗
16. Pascu, M.L. (2017). Laser Optofluidics in Fighting Multiple Drug Resistance, Bentham Science Publishers.10.2174/97816810849851170101 ↗
17. Multidrug-Resistant Bacteria in the Community10.1016/j.idc.2016.02.004 ↗
18. USDA Agricultural Research Service, and Allen, H.K. (2017). Alternatives to Antibiotics: Why and How. NAM Perspect., 7.10.31478/201707g ↗
19. Multiple non-psychiatric effects of phenothiazines: A review10.1016/j.ejphar.2010.08.045 ↗
20. EPR spectroscopy of chlorpromazine-induced free radical formation in normal human melanocytes10.1007/s00249-015-1029-6 ↗
21. Molecular cytotoxic mechanisms of chlorpromazine in isolated rat hepatocytes10.1139/cjpp-2012-0223 ↗
22. Exposure of Chlorpromazine to 266 nm Laser Beam Generates New Species with Antibacterial Properties: Contributions to Development of a New Process for Drug Discovery10.1371/journal.pone.0055767 ↗
23. Characterization of mixtures of compounds produced in chlorpromazine aqueous solutions by ultraviolet laser irradiation: Their applications in antimicrobial assays10.1117/1.JBO.20.5.051002 ↗
24. Drug-Induced Photosensitivity: Culprit Drugs, Management and Prevention10.2165/11592780-000000000-00000 ↗
25. Vlad, I.M., Nuta, D.C., Chirita, C., Caproiu, M.T., Draghici, C., Dumitrascu, F., Bleotu, C., Avram, S., Udrea, A.M., and Missir, A.V. (2020). In Silico and In Vitro Experimental Studies of New Dibenz[b,e]oxepin-11(6H)one O-(arylcarbamoyl)-oximes Designed as Potential Antimicrobial Agents. Molecules, 25.10.3390/molecules25020321 ↗
26. Design, Synthesis and Biopharmacological Profile Evaluation of New 2-((4- Chlorophenoxy)Methyl)-N-(Arylcarbamothioyl)Benzamides with Broad Spectrum Antifungal Activity10.2174/1385272823666190621162950 ↗
27. Time Stability of Laser Exposed Phenothiazines Aqueous Solutions in View of Antimicrobial Research
28. Chlorpromazine transformation by exposure to ultraviolet laser beams in droplet and bulk10.1016/j.ejps.2015.09.017 ↗
29. Determination of minimum inhibitory concentrations10.1093/jac/48.suppl_1.5 ↗
30. Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity10.1016/j.jconrel.2015.01.037 ↗
31. Interaction of solutions containing phenothiazines exposed to laser radiation with materials surfaces, in view of biomedical applications10.1016/j.ijpharm.2014.08.031 ↗
32. Toxicity study in blood and tumor cells of laser produced medicines for application in fabrics10.1016/j.colsurfb.2015.06.041 ↗
33. Bacterial adherence to cotton and silk sutures
34. The Kalimantacin Polyketide Antibiotics Inhibit Fatty Acid Biosynthesis in Staphylococcus aureus by Targeting the Enoyl-Acyl Carrier Protein Binding Site of FabI10.1002/anie.201915407 ↗
35. Crystal structure of FtsA from Staphylococcus aureus10.1016/j.febslet.2014.04.008 ↗
36. Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis10.1021/jacs.6b12565 ↗
37. Crystal Structures of Penicillin-Binding Protein 3 (PBP3) from Methicillin-Resistant Staphylococcus aureus in the Apo and Cefotaxime-Bound Forms10.1016/j.jmb.2012.07.012 ↗
38. Structural and kinetic analyses of penicillin-binding protein 4 (PBP4)-mediated antibiotic resistance in Staphylococcus aureus10.1074/jbc.RA118.004952 ↗
39. Crystal Structures of Penicillin-Binding Protein 3 from Pseudomonas aeruginosa: Comparison of Native and Antibiotic-Bound Forms10.1016/j.jmb.2010.10.024 ↗
40. Structural Analysis of the Role of Pseudomonas aeruginosa Penicillin-Binding Protein 5 in β-Lactam Resistance10.1128/AAC.00505-13 ↗
41. Crystal Structure of Penicillin-Binding Protein 3 (PBP3) from Escherichia coli10.1371/journal.pone.0098042 ↗
42. Harris, J.R., and Marles-Wright, J. (2019). Macromolecular Protein Complexes II: Structure and Function, Springer International Publishing. Subcellular Biochemistry.10.1007/978-3-030-28151-9 ↗
43. Mutational Analysis of Class A and Class B Penicillin-Binding Proteins in Streptococcus gordonii10.1128/AAC.00677-06 ↗
44. The penicillin-binding proteins: Structure and role in peptidoglycan biosynthesis10.1111/j.1574-6976.2008.00105.x ↗
45. Chen, W., Zhang, Y.-M., and Davies, C. (2016). Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 61.10.1128/AAC.01651-16 ↗
46. Role of Pseudomonas aeruginosa Low-Molecular-Mass Penicillin-Binding Proteins in AmpC Expression, β-Lactam Resistance, and Peptidoglycan Structure10.1128/AAC.05150-14 ↗
47. BIOVIA (2019). Dassault Systèmes, [Discovery Studio Visualizer], [V20.1.0.19295], Dassault Systèmes.
48. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility10.1002/jcc.21256 ↗
49. Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking10.1016/j.jphotobiol.2020.111997 ↗
50. Mitchell, M. (1996). An Introduction to Genetic Algorithms, MIT Press. Complex Adaptive Systems.
51. Micellar Properties of a Phenothiazine Drug in Presence of Additives10.1134/S1061933X09040115 ↗
52. In vitro antimicrobial efficacy of laser exposed chlorpromazine against Gram-positive bacteria in planktonic and biofilm growth state10.1016/j.micpath.2019.02.012 ↗
53. Grimsey, E.M., and Piddock, L.J.V. (2019). Do phenothiazines possess antimicrobial and efflux inhibitory properties?. FEMS Microbiol. Rev., fuz017.10.1093/femsre/fuz017 ↗
54. Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis10.1016/S0924-8579(00)00199-0 ↗
55. Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity10.1371/journal.pone.0189950 ↗
56. Chlorpromazine-impregnated catheters as a potential strategy to control biofilm-associated urinary tract infections10.2217/fmb-2019-0092 ↗